About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) filed an amicus brief with the U.S. Supreme Court in the U.S. Food and Drug Administration (FDA) v. Alliance for Hippocratic Medicine case. Arguing in support of the FDA, the PhRMA brief supports the U.S. Fifth Circuit Court of Appeals’ (Fifth Circuit) decision to leave in place the 2000 FDA approval at issue in the district court. Importantly, the amicus brief also argues the Fifth Circuit should also have left in place the 2016 FDA-approved changes to the relevant risk evaluation and mitigation strategy (REMS).
PhRMA Amicus Brief with the U Supreme Court in Support of FDA image
Report
FDA
PhRMA Amicus Brief with the U Supreme Court in Support of FDA
PhRMA Amicus Brief with the U Supreme Court in Support of FDA image